Companies: 10,795·Total market cap: $144.5T
Zura Bio Limited

Zura Bio Limited

ZURANASDAQHealthcare● Active
$3.53
+$0.13(+3.82%)
Market Cap$229527586
P/E Ratio
52W High$7.44
52W Low$1
Overview

Zura Bio Limited(ZURA)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

zura · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

SellBuy

Buy

7 位分析师

共识

评级分布

Strong Buy
1
Buy
5
Hold
1
Sell
0
Strong Sell
0
合计: 7 · 买入占比: 85.7%

12 个月目标价

High

$15.00

Consensus

$15.00

+324.9% upside

Low

$15.00

Median: $15 · Last Close: $3.53

Zura Bio Limited(ZURA)的分析师共识为 Buy,基于过去 3 个月内 7 位华尔街分析师的评级。ZURA 的 12 个月平均目标价为 $15.00,相对当前价 $3.53 代表 +324.9% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.355.00%

1-day model range: $3.32–$3.39. Peak: $3.39 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%21%79%
0Buy
3Neutral
11Sell
RSI (14)36.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ZURA · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.71SELL
MA 10$3.98SELL
MA 20$4.23SELL
MA 50$4.99SELL
MA 100$5.59SELL
MA 200$0.00NEUTRAL
Current $ZURA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.69SELL
EMA 10$3.90SELL
EMA 20$4.20SELL
EMA 50$4.79SELL
EMA 100$4.96SELL
EMA 200$0.00NEUTRAL
Current $ZURA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Chardan Capital2026-03-23
Maintains
BuyBuy
Oppenheimer2026-03-20
Maintains
OutperformOutperform
Chardan Capital2025-11-14
Maintains
BuyBuy
Chardan Capital2025-09-30
Maintains
BuyBuy
HC Wainwright & Co.2025-08-19
Maintains
NeutralNeutral
Chardan Capital2025-08-15
Maintains
BuyBuy
Oppenheimer2025-08-15
Maintains
OutperformOutperform
Oppenheimer2025-05-09
Maintains
OutperformOutperform
HC Wainwright & Co.2025-04-03
Maintains
NeutralNeutral
Oppenheimer2025-03-26
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Zura Bio Limited (ZURA) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover ZURA.

分析师推荐趋势

Buy ratings02↑ +2
Hold ratings101
Sell ratings00

ZURA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$8M

↑ 0.0% YoY

Revenue Next Year

$11M

↑ 28.6% YoY

EPS This Year

$-0.78

EPS Next Year

$-0.69

↓ 11.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ZURA EPS of $-0.78 for the current fiscal year, based on estimates from 4 analysts. The ZURA revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ZURA 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ZURA 的共识目标价为 $15.00(+324.9% 上行空间),分析师共识为 Buy。

ZURA 的短期预测(明日)为 $3.35(-5.00%)。

Zura Bio Limited 在 NASDAQ 上市,代码 ZURA。ZURA 在 2027 年的整体展望偏积极,在覆盖分析师中约 86% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ZURA 预测 · 8 个问题

根据 7 位华尔街分析师,ZURA 的 12 个月平均目标价为 $15.00,最高 $15.00、最低 $15.00。若有图表,中位目标价可在上方查看。相对当前价 $3.53,隐含约 +324.9% 的上行空间。

ZURA 目标价ZURA 分析师目标价ZURA 12个月目标价目标价 ZURA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.